Filter News
Area of Research
- (-) Biology and Environment (14)
- Advanced Manufacturing (2)
- Clean Energy (30)
- Computer Science (1)
- Energy Frontier Research Centers (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (12)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (2)
- Materials (44)
- Materials for Computing (4)
- National Security (14)
- Neutron Science (43)
- Nuclear Science and Technology (8)
- Sensors and Controls (1)
- Supercomputing (38)
News Topics
- (-) Advanced Reactors (1)
- (-) Artificial Intelligence (3)
- (-) Grid (1)
- (-) Machine Learning (2)
- (-) Microscopy (3)
- (-) Nanotechnology (5)
- (-) Neutron Science (3)
- (-) Nuclear Energy (1)
- (-) Security (1)
- (-) Transformational Challenge Reactor (1)
- 3-D Printing/Advanced Manufacturing (7)
- Big Data (1)
- Bioenergy (9)
- Biology (17)
- Biomedical (5)
- Biotechnology (5)
- Buildings (2)
- Chemical Sciences (8)
- Climate Change (7)
- Composites (3)
- Computer Science (5)
- Coronavirus (7)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (5)
- Environment (13)
- Fusion (1)
- High-Performance Computing (5)
- Isotopes (2)
- Materials (10)
- Materials Science (4)
- Molten Salt (1)
- National Security (1)
- Net Zero (1)
- Partnerships (5)
- Physics (1)
- Polymers (1)
- Simulation (4)
- Summit (3)
- Sustainable Energy (4)
- Transportation (2)
Media Contacts
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.